001540 — AHN-GOOK PHARMACEUTICAL Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapContrarian

Annual cashflow statement for AHN-GOOK PHARMACEUTICAL Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	—	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	3,744	6,879	998	16,343	7,319
Depreciation
Amortisation
Non-Cash Items	4,170	9,126	10,016	-3,140	7,405
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-10,949	-19,147	-17,365	-15,987	22,181
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	1,472	1,788	-1,328	4,914	45,683
Capital Expenditures	-4,035	-2,931	-5,474	-75,887	-8,465
Purchase of Fixed Assets
Other Investing Cash Flow Items	7,154	9,362	22,660	500	-3,933
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities	3,118	6,431	17,186	-75,386	-12,398
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-3,846	-3,728	-5,093	57,198	-10,244
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	881	4,569	10,772	-13,147	23,104